申请人:Leibniz-Institut Für Naturstoff-Forschung Und Infektionsbiologie, Hans Knöll Institut
公开号:US20150197539A1
公开(公告)日:2015-07-16
The present invention relates to novel Chartreusin analogues of formula (I), pharmaceutical compositions comprising the same and to their use for the treatment of cancer and other diseases.